Fracture risk in users of oral anticoagulants: A nationwide case-control study
Authors:
- Lars RejnmarkLRLars Rejnmark
- Peter VestergaardPVPeter Vestergaard
- Leif MosekildeLMLeif Mosekilde
- 1 June 2007
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 118 (3) , 338-344
Abstract
No abstract availableKeywords
Funding Information
- Sundhed og Sygdom, Det Frie Forskningsråd
This publication has 28 references indexed in Scilit:
- Oral anticoagulants and the risk of osteoporotic fractures among elderlyPharmacoepidemiology and Drug Safety, 2003
- RETRACTED: Amelioration of osteoporosis by menatetrenone in elderly female Parkinson’s disease patients with vitamin D deficiencyBone, 2002
- Strong Prediction of Fractures Among Older Adults by the Ratio of Carboxylated to Total Serum OsteocalcinJournal of Bone and Mineral Research, 2000
- Vitamin K2 (Menatetrenone) Effectively Prevents Fractures and Sustains Lumbar Bone Mineral Density in OsteoporosisJournal of Bone and Mineral Research, 2000
- Alcohol Intake, Beverage Preference, and Risk of Hip Fracture in Men and WomenAmerican Journal of Epidemiology, 1999
- Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: A three year follow-up studyBone, 1996
- Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly womenJournal of Bone and Mineral Research, 1994
- Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fractureJournal of Bone and Mineral Research, 1993
- Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.Journal of Clinical Investigation, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987